Oramed Granted Japanese Patent for Combination Insulin and GLP-1 Analog Capsule

JERUSALEM, June 27, 2017 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Japanese Intellectual Property Office has publicized its intent to grant Oramed a patent titled, “Methods and Compositions for Treating Diabetes” The patent covers Oramed’s invention of […]